Cardinal Health (NYSE: CAH) reported Q2 EPS of $1.27, $0.01 better than the analyst estimate of $1.26. Revenue for the quarter came in at $45.5 billion versus the consensus estimate of $45.57 billion.

GUIDANCE:

Cardinal Health sees FY2022 EPS of $5.15-$5.50, versus the consensus of $5.37.

• The company updated its fiscal year 2022 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $5.15 to $5.50, from $5.60 to $5.90.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.